Preclinical evidence for the pharmacological actions of naringin: A review

Planta Medica

Volumn 80, Issue 6, 2014, Pages 437-451

  Bharti, Saurabh ^a   Rani, Neha ^a   Krishnamurthy, Bhaskar ^a   Arya, Dharamvir Singh ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

allergy; anti inflammatory; antioxidant; atherosclerosis; bone diseases; cancer; cardiovascular disorders; dentistry; diabetes mellitus; drug interaction; flavonoid; gastrointestinal diseases; hepatoprotection; metabolic syndrome; naringin; nephroprotection; neurological disorders; pharmacokinetics

Indexed keywords

ALKALINE PHOSPHATASE; AURANTIIN; BONE MORPHOGENETIC PROTEIN 2; CAFFEINE; CELL PROTEIN; COLCHICINE; CYTOCHROME P450 3A1; CYTOCHROME P450 3A2; CYTOCHROME P450 3A4; DOXORUBICIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MINOXIDIL; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOCALCIN; OSTEOPONTIN; PACLITAXEL; PARACETAMOL; PITAVASTATIN; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; XANTHINE OXIDASE; ANTIINFLAMMATORY AGENT; FLAVANONE DERIVATIVE; PLANT EXTRACT;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ATHEROSCLEROSIS; BACTERIAL GROWTH; BONE DISEASE; CARDIOVASCULAR DISEASE; CELL ADHESION; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC BRONCHITIS; COGNITIVE DEFECT; COLON CANCER; CONTACT DERMATITIS; CYTOTOXICITY; DERMATOLOGY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG METABOLISM; DRUG SCREENING; ENDOCYTOSIS; ENERGY METABOLISM; EPILEPTIC STATE; EYE DISEASE; GASTROINTESTINAL DISEASE; GLUCOSE INTOLERANCE; HUMAN; INFECTION; INFLAMMATORY BOWEL DISEASE; KIDNEY ISCHEMIA; LIPID PEROXIDATION; LIVER CANCER; LIVER CELL; LIVER PROTECTION; LUNG CANCER; METABOLIC DISORDER; MOUTH CANCER; NEPHROTOXICITY; NEUROGENIC INFLAMMATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; OSTEOCLASTOGENESIS; OSTEOLYSIS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN PHOSPHORYLATION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; REVIEW; SALMONELLA TYPHIMURIUM; SMOOTH MUSCLE FIBER; SOFT TISSUE TUMOR; TOOTH DISEASE; URINARY TRACT CANCER; VASCULAR SMOOTH MUSCLE; WATER IMMERSION; ANIMAL; CHEMISTRY; CITRUS; DRUG EFFECTS; FRUIT; HERB DRUG INTERACTION; PHYTOTHERAPY; TOMATO;

CITRUS; LYCOPERSICON ESCULENTUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; CITRUS; FLAVANONES; FRUIT; HERB-DRUG INTERACTIONS; LYCOPERSICON ESCULENTUM; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 84899487084     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0034-1368351     Document Type: Review

References (208)

1. Rangaswami S., Seshadri T. R., Veeraraghaviah J. Constitution of naringin. The position of the sugar group. J Proc Ind Acad Sci: 1939; 9 328 332
2. Sinclair W. B. The grapefruit: its composition, physiology & products. Berkeley UC ANR publications: 1972; 134
3. Ho P. C., Saville D. J., Coville P. F., Wanwimolruk S. Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products. Pharm Acta Helv: 2000; 74 379 385
4. Hungria M., Johnston A. W., Phillips D. A. Effects of flavonoids released naturally from bean (Phaseolus vulgaris) on nodD-regulated gene transcription in Rhizobium leguminosarum bv. phaseoli. Mol Plant Microbe Interact: 1992; 5 199 203
5. Wang H., Nair M. G., Strasburg G. M., Booren A. M., Gray J. I. Antioxidant polyphenols from tart cherries (Prunus cerasus). J Agric Food Chem: 1999; 47 840 844
6. Sánchez-Rabaneda F., Jáuregui O., Casals I., Andrés-Lacueva C., Izquierdo-Pulido M., Lamuela-Raventós R. M. Liquid chromatographic/electrospray ionization tandem mass spectrometric study of the phenolic composition of cocoa (Theobroma cacao). J Mass Spectrom: 2003; 38 35 42
7. Exarchou V., Godejohann M., van Beek T. A., Gerothanassis I. P., Vervoort J. LC-UV-solid-phase extraction-NMR-MS combined with a cryogenic flow probe and its application to the identification of compounds present in Greek oregano. Anal Chem: 2003; 75 6288 6294
8. Minoggio M., Bramati L., Simonetti P., Gardana C., Iemoli L., Santangelo E., Mauri P. L., Spigno P., Soressi G. P., Pietta P. G. Polyphenol pattern and antioxidant activity of different tomato lines and cultivars. Ann Nutr Metab: 2003; 47 64 69
9. Rouseff R. L., Martin S. F., Youtsey C. O. Quantitative survey of narirutin, naringin, hesperidin, and neohesperidin in citrus. J Agric Food Chem: 1987; 35 1027 1030
10. Asahina Y., Inubuse M. Über die Konstitution des Naringenins (II. Mitteilung über die Flavanon-Glucoside). Chemische Berichte: 1928; 61 1514
11. Braverman J. BS. Citrus products. Chemical composition and chemical technology. New York Interscience Publishers: 1949; 424
12. Tomasik P. Chemical and functional properties of food saccharides. Boca Raton CRC Press: 2004; 389
13. Wilcox L. J., Borradaile N. M., Huff M. W. Antiatherogenic properties of naringenin, a citrus flavonoid. Cardiovasc Drug Rev: 1999; 17 160 178
14. Chanet A., Milenkovic D., Manach C., Mazur A., Morand C. Citrus flavanones: what is their role in cardiovascular protection? J Agric Food Chem: 2012; 60 8809 8822
15. Benavente-García O., Castillo J. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem: 2008; 56 6185 6205
16. Liu M., Yang C., Zou W., Guan X., Zheng W., Lai L., Fang S., Cai S., Su W. Toxicokinetics of naringin, a putative antitussive, after 184-day repeated oral administration in rat. Environ Toxicol Pharmacol: 2011; 31 485 489
17. Wang M. J., Chao P. DL, Hou Y. C., Hsiu S. L., Wen K. C., Tsai S. Y. Pharmacokinetics and conjugation metabolism of naringin and naringenin in rats after single dose and muliple dose administration. J Food Drug Anal: 2006; 14 247 253
18. Tsai Y. J., Tsai T. H. Mesenteric lymphatic absorption and the pharmacokinetics of naringin and naringenin in the rat. J Agric Food Chem: 2012; 60 12435 12442
19. Fang T., Wang Y., Ma Y., Su W., Bai Y., Zhao P. A rapid LC/MS/MS quantitation assay for naringin and its two metabolites in rats plasma. J Pharm Biomed Anal: 2006; 40 454 459
20. Felgines C., Texier O., Morand C., Manach C., Scalbert A., Régerat F., Rémésy C. Bioavailability of the flavanone naringenin and its glycosides in rats. Am J Physiol Gastrointest Liver Physiol: 2000; 279 G1148 G1154
21. Hsiu S. L., Huang T. Y., Hou Y. C., Chin D. H., Chao P. D. Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits. Life Sci: 2002; 70 1481 1489
22. Liu M., Zou W., Yang C., Peng W., Su W. Metabolism and excretion studies of oral administered naringin, a putative antitussive, in rats and dogs. Biopharm Drug Dispos: 2012; 33 123 134
23. Mata-Bilbao Mde L., Andrés-Lacueva C., Roura E., Jáuregui O., Escribano E., Torre C., Lamuela-Raventós R. M. Absorption and pharmacokinetics of grapefruit flavanones in beagles. Br J Nutr: 2007; 98 86 92
24. Ishii K., Furuta T., Kasuya Y. Determination of naringin and naringenin in human urine by high-performance liquid chromatography utilizing solid-phase extraction. J Chromatogr B Biomed Sci Appl: 1997; 704 299 305
25. Ameer B., Weintraub R. A., Johnson J. V., Yost R. A., Rouseff R. L. Flavanone absorption after naringin, hesperidin, and citrus administration. Clin Pharmacol Ther: 1996; 60 34 40
26. Kanaze F. I., Kokkalou E., Georgarakis M., Niopas I. A validated solid-phase extraction HPLC method for the simultaneous determination of the citrus flavanone aglycones hesperetin and naringenin in urine. J Pharm Biomed Anal: 2004; 36 175 181
27. Kim D. H., Jung E. A., Sohng I. S., Han J. A., Kim T. H., Han M. J. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch Pharm Res: 1998; 21 17 23
28. Griffiths L. A., Smith G. E. Metabolism of myricetin and related compounds in the rat. Metabolite formation in vivo and by the intestinal microflora in vitro. Biochem J: 1972; 130 141 151
29. Griffiths L. A., Barrow A. Metabolism of flavonoid compounds in germ-free rats. Biochem J: 1972; 130 1161 1162
30. Nikolic D., van Breemen R. B. New metabolic pathways for flavanones catalyzed by rat liver microsomes. Drug Metab Dispos: 2004; 32 387 397
31. Li X., Xiao H., Liang X., Shi D., Liu J. LC-MS/MS determination of naringin, hesperidin and neohesperidin in rat serum after orally administrating the decoction of Bulpleurum falcatum L. and Fractus aurantii. J Pharm Biomed Anal: 2004; 27 159 166
32. Zou W., Yang C., Liu M., Su W. Tissue distribution study of naringin in rats by liquid chromatography-tandem mass spectrometry. Arzneimittelforschung: 2012; 62 181 186
33. Tsai T. H. Determination of naringin in rat blood, brain, liver, and bile using microdialysis and its interaction with cyclosporin a, a p-glycoprotein modulator. J Agric Food Chem: 2002; 50 6669 6674
34. Fuhr U., Kummert A. L. The fate of naringin in humans: a key to grapefruit juice-drug interactions? Clin Pharmacol Ther: 1995; 58 365 373
35. Shirasaka Y., Suzuki K., Shichiri M., Nakanishi T., Tamai I. Intestinal absorption of HMG-CoA reductase inhibitor pitavastatin mediated by organic anion transporting polypeptide and P-glycoprotein/multidrug resistance 1. Drug Metab Pharmacokinet: 2011; 26 171 179
36. Yamakawa Y., Hamada A., Shuto T., Yuki M., Uchida T., Kai H., Kawaguchi T., Saito H. Pharmacokinetic impact of SLCO1A2 polymorphisms on imatinib disposition in patients with chronic myeloid leukemia. Clin Pharmacol Ther: 2011; 90 157 163
37. Nishimuta H., Ohtani H., Tsujimoto M., Ogura K., Hiratsuka A., Sawada Y. Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3. Biopharm Drug Dispos: 2007; 28 491 500
38. Walle T., Eaton E. A., Walle U. K. Quercetin, a potent and specific inhibitor of the human P-form phenosulfotransferase. Biochem Pharmacol: 1995; 50 731 734
39. Dahan A., Amidon G. L. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein. Pharm Res: 2009; 26 883 892
40. Yeum C. H., Choi J. S. Effect of naringin pretreatment on bioavailability of verapamil in rabbits. Arch Pharm Res: 2006; 29 102 107
41. Lim S. C., Choi J. S. Effects of naringin on the pharmacokinetics of intravenous paclitaxel in rats. Biopharm Drug Dispos: 2006; 27 443 447
42. Park H. S., Oh J. H., Lee J. H., Lee Y. J. Minor effects of the citrus flavonoids naringin, naringenin and quercetin, on the pharmacokinetics of doxorubicin in rats. Pharmazie: 2011; 66 424 429
43. Ballard T. L., Halaweish F. T., Stevermer C. L., Agrawal P., Vukovich M. D. Naringin does not alter caffeine pharmacokinetics, energy expenditure, or cardiovascular haemodynamics in humans following caffeine consumption. Clin Exp Pharmacol Physiol: 2006; 33 310 314
44. Ali M. M., Agha F. G., El-Sammad N. M., Hassan S. K. Modulation of anticancer drug-induced P-glycoprotein expression by naringin. Z Naturforsch C: 2009; 64 109 116
45. Guengerich F. P., Kim D. H. In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis: 1990; 11 2275 2279
46. Chen Y. T., Zheng R. L., Jia Z. J., Ju Y. Flavonoids as superoxide scavengers and antioxidants. Free Radic Biol Med: 1990; 9 19 21
47. Russo A., Acquaviva R., Campisi A., Sorrenti V., Di Giacomo C., Virgata G., Barcellona M. L., Vanella A. Bioflavonoids as antiradicals, antioxidants and DNA cleavage protectors. Cell Biol Toxicol: 2000; 16 91 98
48. +-loss and lipid peroxidation induced by oxygen free radicals in human red cells. Pharmacol Res Commun: 1986; 18 61 72
49. Kumar M. S., Unnikrishnan M. K., Patra S., Murthy K., Srinivasan K. K. Naringin and naringenin inhibit nitrite-induced methemoglobin formation. Pharmazie: 2003; 58 564 566
50. Karaseva E. I., Kurchenko V. P., Metelitsa D. I. Flavonoids: efficient protectors of glucose-6-phosphate dehydrogenase from ultrasonic cavitation-induced inactivation. Prikl Biokhim Mikrobiol: 2007; 43 158 168
51. Zielińska-Przyjemska M., Ignatowicz E. Citrus fruit flavonoids influence on neutrophil apoptosis and oxidative metabolism. Phytother Res: 2008; 22 1557 1562
52. Jagetia G. C., Reddy T. K., Venkatesha V. A., Kedlaya R. Influence of naringin on ferric iron induced oxidative damage in vitro. Clin Chim Acta: 2004; 347 189 197
53. Jagetia G. C., Reddy T. K. Alleviation of iron induced oxidative stress by the grape fruit flavanone naringin in vitro. Chem Biol Interact: 2011; 190 121 128
54. Kim S. W., Kim C. E., Kim M. H. Flavonoids inhibit high glucose-induced up-regulation of ICAM-1 via the p38 MAPK pathway in human vein endothelial cells. Biochem Biophys Res Commun: 2011; 415 602 607
55. Chen J., Guo R., Yan H., Tian L., You Q., Li S., Huang R., Wu K. Naringin Inhibits ROS-activated MAPK Pathway in High Glucose-induced Injuries in H9c2 Cardiac Cells. Basic Clin Pharmacol Toxicol: 2014; 114 293 304
56. Lu Y. H., Su M. Y., Huang H. Y. Lin-Li Yuan C. G. Protective effects of the citrus flavanones to PC12 cells against cytotoxicity induced by hydrogen peroxide. Neurosci Lett: 2010; 484 6 11
57. Gopinath K., Sudhandiran G. Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway. Neuroscience: 2012; 227 134 143
58. Gopinath K., Prakash D., Sudhandiran G. Neuroprotective effect of naringin, a dietary flavonoid against 3-nitropropionic acid-induced neuronal apoptosis. Neurochem Int: 2011; 59 1066 1073
59. Kanno S., Shouji A., Asou K., Ishikawa M. Effects of naringin on hydrogen peroxide-induced cytotoxicity and apoptosis in P388 cells. J Pharmacol Sci: 2003; 92 166 170
60. Kanno S., Shouji A., Hirata R., Asou K., Ishikawa M. Effects of naringin on cytosine arabinoside (Ara-C)-induced cytotoxicity and apoptosis in P388 cells. Life Sci: 2004; 75 353 365
61. Yeh S. L., Wang W. Y., Huang C. H., Hu M. L. Pro-oxidative effect of beta-carotene and the interaction with flavonoids on UVA-induced DNA strand breaks in mouse fibroblast C3H10 T1/2 cells. J Nutr Biochem: 2005; 16 729 735
62. Benkovic V., Knezevic A. H., Orsolic N., Basic I., Ramic S., Viculin T., Knezevic F., Kopjar N. Evaluation of radioprotective effects of propolis and its flavonoid constituents: in vitro study on human white blood cells. Phytother Res: 2009; 23 1159 1168
63. Yilmaz D., Aydemir N. C., Vatan O., Tüzün E., Bilaloglu R. Influence of naringin on cadmium-induced genomic damage in human lymphocytes in vitro. Toxicol Ind Health: 2012; 28 114 121
64. Jagetia A., Jagetia G. C., Jha S. Naringin, a grapefruit flavanone, protects V79 cells against the bleomycin-induced genotoxicity and decline in survival. J Appl Toxicol: 2007; 27 122 132
65. Hori M., Kojima H., Nakata S., Konishi H., Kitagawa A., Kawai K. A search for the plant ingredients that protect cells from air pollutants and benz[a]pyrene phototoxicity. Drug Chem Toxicol: 2007; 30 105 116
66. Cavia-Saiz M., Busto M. D., Pilar-Izquierdo M. C., Ortega N., Perez-Mateos M., Muñiz P. Antioxidant properties, radical scavenging activity and biomolecule protection capacity of flavonoid naringenin and its glycoside naringin: a comparative study. J Sci Food Agric: 2010; 90 1238 1244
67. Pereira R. M., Andrades N. E., Paulino N., Sawaya A. C., Eberlin M. N., Marcucci M. C., Favero G. M., Novak E. M., Bydlowski S. P. Synthesis and characterization of a metal complex containing naringin and Cu, and its antioxidant, antimicrobial, antiinflammatory and tumor cell cytotoxicity. Molecules: 2007; 12 1352 1366
68. Anh N. T., Nishitani M., Harada S., Yamaguchi M., Kamei K. A Drosophila model for the screening of bioavailable NADPH oxidase inhibitors and antioxidants. Mol Cell Biochem: 2011; 352 91 98
69. Bodas R., Prieto N., López-Campos O., Giráldez F. J., Andrés S. Naringin and vitamin E influence the oxidative stability and lipid profile of plasma in lambs fed fish oil. Res Vet Sci: 2011; 91 98 102
70. Jeon S. M., Bok S. H., Jang M. K., Kim Y. H., Nam K. T., Jeong T. S., Park Y. B., Choi M. S. Comparison of antioxidant effects of naringin and probucol in cholesterol-fed rabbits. Clin Chim Acta: 2002; 317 181 190
71. Jeon S. M., Bok S. H., Jang M. K., Lee M. K., Nam K. T., Park Y. B., Rhee S. J., Choi M. S. Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits. Life Sci: 2001; 69 2855 2866
72. Singh D., Chopra K. The effect of naringin, a bioflavonoid on ischemia-reperfusion induced renal injury in rats. Pharmacol Res: 2004; 50 187 193
73. Akondi B. R., Challa S. R., Akula A. Protective effects of rutin and naringin in testicular ischemia-reperfusion induced oxidative stress in rats. J Reprod Infertil: 2011; 12 209 214
74. Amudha K., Pari L. Beneficial role of naringin, a flavanoid on nickel induced nephrotoxicity in rats. Chem Biol Interact: 2011; 193 57 64
75. Pari L., Amudha K. Hepatoprotective role of naringin on nickel-induced toxicity in male Wistar rats. Eur J Pharmacol: 2011; 650 364 370
76. Singh D., Chander V., Chopra K. Protective effect of naringin, a bioflavonoid on ferric nitrilotriacetate-induced oxidative renal damage in rat kidney. Toxicology: 2004; 201 1 8
77. Singh D., Chander V., Chopra K. Protective effect of naringin, a bioflavonoid on glycerol-induced acute renal failure in rat kidney. Toxicology: 2004; 201 143 151
78. Cariño-Cortés R., Alvarez-González I., Martino-Roaro L., Madrigal-Bujaidar E. Effect of naringin on the DNA damage induced by daunorubicin in mouse hepatocytes and cardiocytes. Biol Pharm Bull: 2010; 33 697 701
79. Attia S. M. Abatement by naringin of lomefloxacin-induced genomic instability in mice. Mutagenesis: 2008; 23 515 521
80. Mahmoud A. M., Ashour M. B., Abdel-Moneim A., Ahmed O. M. Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. J Diabetes Complications: 2012; 26 483 490
81. Bakheet S. A., Attia S. M. Evaluation of chromosomal instability in diabetic rats treated with naringin. Oxid Med Cell Longev: 2011; 2011 365292
82. Jagetia G. C., Reddy T. K. Modulation of radiation-induced alteration in the antioxidant status of mice by naringin. Life Sci: 2005; 77 780 794
83. Jagetia G. C., Venkatesha V. A., Reddy T. K. Naringin, a citrus flavonone, protects against radiation-induced chromosome damage in mouse bone marrow. Mutagenesis: 2003; 18 337 343
84. Orsolić N., Benković V., Horvat-Knezević A., Kopjar N., Kosalec I., Bakmaz M., Mihaljević Z., Bendelja K., Basić I. Assessment by survival analysis of the radioprotective properties of propolis and its polyphenolic compounds. Biol Pharm Bull: 2007; 30 946 951
85. Kanno S., Shouji A., Tomizawa A., Hiura T., Osanai Y., Ujibe M., Obara Y., Nakahata N., Ishikawa M. Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages. Life Sci: 2006; 78 673 681
86. Liu Y., Su W. W., Wang S., Li P. B. Naringin inhibits chemokine production in an LPS-induced RAW 264.7 macrophage cell line. Mol Med Report: 2012; 6 1343 1350
87. Si-Si W., Liao L., Ling Z., Yun-Xia Y. Inhibition of TNF- α /IFN- γ induced RANTES expression in HaCaT cell by naringin. Pharm Biol: 2011; 49 810 814
88. Santos M. L., Toyama D. O., Oliveira S. C., Cotrim C. A., Diz-Filho E. B., Fagundes F. H., Soares V. C., Aparicio R., Toyama M. H. Modulation of the pharmacological activities of secretory phospholipase A2 from Crotalus durissus cascavella induced by naringin. Molecules: 2011; 16 738 761
89. Xiong Y., Wang G. F., Zhang J. Y., Wu S. Y., Xu W., Zhang J. J., Wu S. G., Rao J. J. Naringin inhibits monocyte adhesion to high glucose-induced human umbilical vein endothelial cells. Nan Fang Yi Ke Da Xue Xue Bao: 2010; 30 321 325
90. Lee J. H., Kim G. H. Evaluation of antioxidant and inhibitory activities for different subclasses flavonoids on enzymes for rheumatoid arthritis. J Food Sci: 2010; 75 H212 H217
91. Prota L., Santoro A., Bifulco M., Aquino R. P., Mencherini T., Russo P. Leucine enhances aerosol performance of naringin dry powder and its activity on cystic fibrosis airway epithelial cells. Int J Pharm: 2011; 412 8 19
92. Kawaguchi K., Kikuchi S., Hasegawa H., Maruyama H., Morita H., Kumazawa Y. Suppression of lipopolysaccharide-induced tumor necrosis factor-release and liver injury in mice by naringin. Eur J Pharmacol: 1999; 368 245 250
93. Liu Y., Wu H., Nie Y. C., Chen J. L., Su W. W., Li P. B. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF- κ B pathway. Int Immunopharmacol: 2011; 11 1606 1612
94. Shiratori K., Ohgami K., Ilieva I., Jin X. H., Yoshida K., Kase S., Ohno S. The effects of naringin and naringenin on endotoxin-induced uveitis in rats. J Ocul Pharmacol Ther: 2005; 21 298 304
95. Nie Y. C., Wu H., Li P. B., Luo Y. L., Long K., Xie L. M., Shen J. G., Su W. W. Anti-inflammatory effects of naringin in chronic pulmonary neutrophilic inflammation in cigarette smoke-exposed rats. J Med Food: 2012; 15 894 900
96. Luo Y. L., Zhang C. C., Li P. B., Nie Y. C., Wu H., Shen J. G., Su W. W. Naringin attenuates enhanced cough, airway hyperresponsiveness and airway inflammation in a guinea pig model of chronic bronchitis induced by cigarette smoke. Int Immunopharmacol: 2012; 13 301 307
97. Luo Y. L., Li P. B., Zhang C. C., Zheng Y. F., Wang S., Nie Y. C., Zhang K. J., Su W. W. Effects of four antitussives on airway neurogenic inflammation in a guinea pig model of chronic cough induced by cigarette smoke exposure. Inflamm Res: 2013; 62 1053 1061
98. Jain M., Parmar H. S. Evaluation of antioxidative and anti-inflammatory potential of hesperidin and naringin on the rat air pouch model of inflammation. Inflamm Res: 2011; 60 483 491
99. Amaro M. I., Rocha J., Vila-Real H., Eduardo-Figueira M., Mota-Filipe H., Sepodes B., Ribeiro M. H. Anti-inflammatory activity of naringin and the biosynthesised naringenin by naringinase immobilized in microstructured materials in a model of DSS-induced colitis in mice. Food Res Int: 2009; 42 1010 1017
100. Golechha M., Chaudhry U., Bhatia J., Saluja D., Arya D. S. Naringin protects against kainic acid-induced status epilepticus in rats: evidence for an antioxidant, anti-inflammatory and neuroprotective intervention. Biol Pharm Bull: 2011; 34 360 365
101. Naderi G. A., Asgary S., Sarraf-Zadegan N., Shirvany H. Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation. Mol Cell Biochem: 2003; 246 193 196
102. Balestrieri M. L., Castaldo D., Balestrieri C., Quagliuolo L., Giovane A., Servillo L. Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress. J Lipid Res: 2003; 44 380 387
103. Lee E. J., Moon G. S., Choi W. S., Kim W. J., Moon S. K. Naringin-induced p21WAF1-mediated G(1)-phase cell cycle arrest via activation of the Ras/Raf/ERK signaling pathway in vascular smooth muscle cells. Food Chem Toxicol: 2008; 46 3800 3807
104. Lee E. J., Kim D. I., Kim W. J., Moon S. K. Naringin inhibits matrix metalloproteinase-9 expression and AKT phosphorylation in tumor necrosis factor-alpha-induced vascular smooth muscle cells. Mol Nutr Food Res: 2009; 53 1582 1591
105. Shin Y. W., Bok S. H., Jeong T. S., Bae K. H., Jeoung N. H., Choi M. S., Lee S. H., Park Y. B. Hypocholesterolemic effect of naringin associated with hepatic cholesterol regulating enzyme changes in rats. Int J Vitam Nutr Res: 1999; 69 341 347
106. Lee C. H., Jeong T. S., Choi Y. K., Hyun B. H., Oh G. T., Kim E. H., Kim J. R., Han J. I., Bok S. H. Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem Biophys Res Commun: 2001; 284 681 688
107. Choe S. C., Kim H. S., Jeong T. S., Bok S. H., Park Y. B. Naringin has an antiatherogenic effect with the inhibition of intercellular adhesion molecule-1 in hypercholesterolemic rabbits. J Cardiovasc Pharmacol: 2001; 38 947 955
108. Jeon S. M., Park Y. B., Choi M. S. Antihypercholesterolemic property of naringin alters plasma and tissue lipids, cholesterol-regulating enzymes, fecal sterol and tissue morphology in rabbits. Clin Nutr: 2004; 23 1025 1034
109. Kim H. J., Oh G. T., Park Y. B., Lee M. K., Seo H. J., Choi M. S. Naringin alters the cholesterol biosynthesis and antioxidant enzyme activities in LDL receptor-knockout mice under cholesterol fed condition. Life Sci: 2004; 74 1621 1634
110. Kim S. Y., Kim H. J., Lee M. K., Jeon S. M., Do G. M., Kwon E. Y., Cho Y. Y., Kim D. J., Jeong K. S., Park Y. B., Ha T. Y., Choi M. S. Naringin time-dependently lowers hepatic cholesterol biosynthesis and plasma cholesterol in rats fed high-fat and high-cholesterol diet. J Med Food: 2006; 9 582 586
111. Chanet A., Milenkovic D., Deval C., Potier M., Constans J., Mazur A., Bennetau-Pelissero C., Morand C., Bérard A. M. Naringin, the major grapefruit flavonoid, specifically affects atherosclerosis development in diet-induced hypercholesterolemia in mice. J Nutr Biochem: 2012; 23 469 477
112. Jung U. J., Kim H. J., Lee J. S., Lee M. K., Kim H. O., Park E. J., Kim H. K., Jeong T. S., Choi M. S. Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. Clin Nutr: 2003; 22 561 568
113. Demonty I., Lin Y., Zebregs Y. E., Vermeer M. A., van der Knaap H. C., Jäkel M., Trautwein E. A. The citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and women. J Nutr: 2010; 140 1615 1620
114. Ajay M., Gilani A. U., Mustafa M. R. Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sci: 2003; 74 603 612
115. Saponara S., Testai L., Iozzi D., Martinotti E., Martelli A., Chericoni S., Sgaragli G., Fusi F., Calderone V. (±)-Naringenin as large conductance Ca2+-activated K+ (BKCa) channel opener in vascular smooth muscle cells. Br J Pharmacol: 2006; 149 1013 1021
116. Yow T. T., Pera E., Absalom N., Heblinski M., Johnston G. A., Hanrahan J. R., Chebib M. Naringin directly activates inwardly rectifying potassium channels at an overlapping binding site to tertiapin-Q. Br J Pharmacol: 2011; 163 1017 1033
117. Huang H., Wu K., You Q., Huang R., Li S., Wu K. Naringin inhibits high glucose-induced cardiomyocyte apoptosis by attenuating mitochondrial dysfunction and modulating the activation of the p38 signaling pathway. Int J Mol Med: 2013; 32 396 402
118. Ikemura M., Sasaki Y., Giddings J. C., Yamamoto J. Preventive effects of hesperidin, glucosyl hesperidin and naringin on hypertension and cerebral thrombosis in stroke-prone spontaneously hypertensive rats. Phytother Res: 2012; 26 1272 1277
119. Rajadurai M., Prince P. S. Preventive effect of naringin on cardiac mitochondrial enzymes during isoproterenol-induced myocardial infarction in rats: a transmission electron microscopic study. J Biochem Mol Toxicol: 2007; 21 354 361
120. Rajadurai M., Prince P. S. Preventive effect of naringin on isoproterenol-induced cardiotoxicity in Wistar rats: an in vivo and in vitro study. Toxicology: 2007; 232 216 225
121. Rajadurai M., Prince P. S. Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats. Toxicology: 2007; 230 178 188
122. Rajadurai M., Prince P. S. Preventive effect of naringin on lipid peroxides and antioxidants in isoproterenol-induced cardiotoxicity in Wistar rats: biochemical and histopathological evidences. Toxicology: 2006; 228 259 268
123. Rani N., Bharti S., Manchanda M., Nag T. C., Ray R., Chauhan S. S., Kumari S., Arya D. S. Regulation of heat shock proteins 27 and 70, p-Akt/p-eNOS and MAPKs by naringin dampens myocardial injury and dysfunction in vivo after ischemia/reperfusion. PLoS One: 2013; 8 e82577
124. Parmar H. S., Jain P., Chauhan D. S., Bhinchar M. K., Munjal V., Yusuf M., Choube K., Tawani A., Tiwari V., Manivannan E., Kumar A. DPP-IV inhibitory potential of naringin: an in silico, in vitro and in vivo study. Diabetes Res Clin Pract: 2012; 97 105 111
125. Purushotham A., Tian M., Belury M. A. The citrus fruit flavonoid naringenin suppresses hepatic glucose production from Fao hepatoma cells. Mol Nutr Food Res: 2009; 53 300 307
126. Jung U. J., Lee M. K., Jeong K. S., Choi M. S. The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J Nutr: 2004; 134 2499 2503
127. Jung U. J., Lee M. K., Park Y. B., Kang M. A., Choi M. S. Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int J Biochem Cell Biol: 2006; 38 1134 1145
128. Leray V., Freuchet B., Le Bloch J., Jeusette I., Torre C., Nguyen P. Effect of citrus polyphenol- and curcumin-supplemented diet on inflammatory state in obese cats. Br J Nutr: 2011; 106 S198 S201
129. Pu P., Gao D. M., Mohamed S., Chen J., Zhang J., Zhou X. Y., Zhou N. J., Xie J., Jiang H. Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet. Arch Biochem Biophys: 2012; 518 61 70
130. Xulu S., Oroma Owira P. M. Naringin ameliorates atherogenic dyslipidemia but not hyperglycemia in rats with type 1 diabetes. J Cardiovasc Pharmacol: 2012; 59 133 141
131. Alam M. A., Kauter K., Brown L. Naringin improves diet-induced cardiovascular dysfunction and obesity in high carbohydrate, high fat diet-fed rats. Nutrients: 2013; 5 637 650
132. Kandhare A. D., Raygude K. S., Ghosh P., Ghule A. E., Bodhankar S. L. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy. Fitoterapia: 2012; 83 650 659
133. Goodarzi M. T., Zal F., Malakooti M., Safari M. R., Sadeghian S. Inhibitory activity of flavonoids on the lens aldose reductase of healthy and diabetic rats. Acta Medica Iranica: 2006; 44 41 45
134. Sharma A. K., Bharti S., Ojha S., Bhatia J., Kumar N., Ray R., Kumari S., Arya D. S. Up-regulation of PPAR γ, heat shock protein-27 and -72 by naringin attenuates insulin resistance, β -cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes. Br J Nutr: 2011; 106 1713 1723
135. Kim H. J., Song J. Y., Park H. J., Park H. K., Yun D. H., Chung J. H. Naringin protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Korean J Physiol Pharmacol: 2009; 13 281 285
136. Wang D., Gao K., Li X., Shen X., Zhang X., Ma C., Qin C., Zhang L. Long-term naringin consumption reverses a glucose uptake defect and improves cognitive deficits in a mouse model of Alzheimer's disease. Pharmacol Biochem Behav: 2012; 102 13 20
137. Maratha S. R., Mahadevan N. Memory enhancing activity of naringin in unstressed and stressed mice: possible cholinergic and nitriergic modulation. Neurochem Res: 2012; 37 2206 2212
138. Gaur V., Aggarwal A., Kumar A. Protective effect of naringin against ischemic reperfusion cerebral injury: possible neurobehavioral, biochemical and cellular alterations in rat brain. Eur J Pharmacol: 2009; 616 147 154
139. Rong W., Wang J., Liu X., Jiang L., Wei F., Hu X., Han X., Liu Z. Naringin treatment improves functional recovery by increasing BDNF and VEGF expression, inhibiting neuronal apoptosis after spinal cord injury. Neurochem Res: 2012; 37 1615 1623
140. Kumar A., Dogra S., Prakash A. Protective effect of naringin, a citrus flavonoid, against colchicine-induced cognitive dysfunction and oxidative damage in rats. J Med Food: 2010; 13 976 984
141. Kumar A., Prakash A., Dogra S. Naringin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress induced by D-galactose in mice. Food Chem Toxicol: 2010; 48 626 632
142. Kumar P., Kumar A. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide. Behav Brain Res: 2010; 206 38 46
143. Aggarwal A., Gaur V., Kumar A. Nitric oxide mechanism in the protective effect of naringin against post-stroke depression (PSD) in mice. Life Sci: 2010; 86 928 935
144. Fernandez S. P., Nguyen M., Yow T. T., Chu C., Johnston G. A., Hanrahan J. R., Chebib M. The flavonoid glycosides, myricitrin, gossypin and naringin exert anxiolytic action in mice. Neurochem Res: 2009; 34 1867 1875
145. Viswanatha G. L., Shylaja H., Rao K. S., Ashwini Y., Kumar V. R., Mohan C. G., Sunil V. G., Kumar M. V., Rajesh S. Amelioration of immobilization stress-induced biochemical and behavioral alterations and mitochondrial dysfunction by naringin in mice: possible mechanism of nitric oxide modulation. Zhong Xi Yi Jie He Xue Bao: 2011; 9 1254 1263
146. Vij G., Gupta A., Chopra K. Modulation of antigen-induced chronic fatigue in mouse model of water immersion stress by naringin, a polyphenolic antioxidant. Fundam Clin Pharmacol: 2009; 23 331 337
147. Lake B. G., Beamand J. A., Tredger J. M., Barton P. T., Renwick A. B., Price R. J. Inhibition of xenobiotic-induced genotoxicity in cultured precision-cut human and rat liver slices. Mutat Res: 1999; 440 91 100
148. Blankson H., Grotterod E. M., Seglen P. O. Prevention of toxin-induced cytoskeletal disruption and apoptotic liver cell death by the grapefruit flavonoid, naringin. Cell Death Differ: 2000; 7 739 746
149. Berven G., Saetre F., Halvorsen K., Seglen P. O. Effects of the diarrhetic shellfish toxin, okadaic acid, on cytoskeletal elements, viability and functionality of rat liver and intestinal cells. Toxicon: 2001; 39 349 362
150. Gordon P. B., Holen I., Seglen P. O. Protection by naringin and some other flavonoids of hepatocytic autophagy and endocytosis against inhibition by okadaic acid. J Biol Chem: 1995; 270 5830 5838
151. Moller M. T., Samari H. R., Fengsrud M., Stromhaug P. E., oStvold A. C., Seglen P. O. Okadaic acid-induced, naringin-sensitive phosphorylation of glycine N-methyltransferase in isolated rat hepatocytes. Biochem J: 2003; 373 505 513
152. Larsen A. K., Moller M. T., Blankson H., Samari H. R., Holden L., Seglen P. O. Naringin-sensitive phosphorylation of plectin, a cytoskeletal cross-linking protein, in isolated rat hepatocytes. J Biol Chem: 2002; 277 34826 34835
153. Seo H. J., Jeong K. S., Lee M. K., Park Y. B., Jung U. J., Kim H. J., Choi M. S. Role of naringin supplement in regulation of lipid and ethanol metabolism in rats. Life Sci: 2003; 73 933 946
154. Oliva J., French B. A., Li J., Bardag-Gorce F., Fu P., French S. W. Sirt1 is involved in energy metabolism: the role of chronic ethanol feeding and resveratrol. Exp Mol Pathol: 2008; 85 155 159
155. So F. V., Guthrie N., Chambers A. F., Moussa M., Carroll K. K. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer: 1996; 26 167 181
156. Froufe H. J., Abreu R. M., Ferreira I. C. Using molecular docking to investigate the anti-breast cancer activity of low molecular weight compounds present on wild mushrooms. SAR QSAR Environ Res: 2011; 22 315 328
157. Guo D., Wang J., Wang X., Luo H., Zhang H., Cao D., Chen L., Huang N. Double directional adjusting estrogenic effect of naringin from Rhizoma drynariae (Gusuibu). J Ethnopharmacol: 2011; 138 451 457
158. Schindler R., Mentlein R. Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J Nutr: 2006; 136 1477 1482
159. Fenton J. I., Hord N. G. Flavonoids promote cell migration in nontumorigenic colon epithelial cells differing in Apc genotype: implications of matrix metalloproteinase activity. Nutr Cancer: 2004; 48 182 188
160. Vanamala J., Leonardi T., Patil B. S., Taddeo S. S., Murphy M. E., Pike L. M., Chapkin R. S., Lupton J. R., Turner N. D. Suppression of colon carcinogenesis by bioactive compounds in grapefruit. Carcinogenesis: 2006; 27 1257 1265
161. Sequetto P. L., Oliveira T. T., Maldonado I. R., Augusto L. E., Mello V. J., Pizziolo V. R., Almeida M. R., Silva M. E., Novaes R. D. Naringin accelerates the regression of pre-neoplastic lesions and the colorectal structural reorganization in a murine model of chemical carcinogenesis. Food Chem Toxicol: 2014; 64 200 209
162. Ramesh E., Alshatwi A. A. Naringin induces death receptor and mitochondria-mediated apoptosis in human cervical cancer (SiHa) cells. Food Chem Toxicol: 2013; 51 97 105
163. Kim D. I., Lee S. J., Lee S. B., Park K., Kim W. J., Moon S. K. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression. Carcinogenesis: 2008; 29 1701 1709
164. Yeh S. L., Wang W. Y., Huang C. S., Hu M. L. Flavonoids suppresses the enhancing effect of beta-carotene on DNA damage induced by 4-(methylnitrosamino) -1-(3-pyridyl)-1-butanone (NNK) in A549 cells. Chem Biol Interact: 2006; 160 175 182
165. Nie Y. C., Wu H., Li P. B., Xie L. M., Luo Y. L., Shen J. G., Su W. W. Naringin attenuates EGF-induced MUC5AC secretion in A549 cells by suppressing the cooperative activities of MAPKs-AP-1 and IKKs-I κ B-NF- κ B signaling pathways. Eur J Pharmacol: 2012; 690 207 213
166. Prabu T., Ragunath M., Manju V. Antioxidant potential of naringin - a dietary flavonoid - in N-nitrosodiethylamine induced rat liver carcinogenesis. Biomed Prev Nutr: 2012; 2 193 202
167. Miller E. G., Peacock J. J., Bourland T. C., Taylor S. E., Wright J. M., Patil B. S., Miller E. G. Inhibition of oral carcinogenesis by citrus flavonoids. Nutr Cancer: 2008; 60 69 74
168. Greinert R., Volkmer B., Henning S., Breitbart E. W., Greulich K. O., Cardoso M. C., Rapp A. UVA-induced DNA double-strand breaks result from the repair of clustered oxidative DNA damages. Nucleic Acids Res: 2012; 40 10263 10273
169. Kanno S., Tomizawa A., Hiura T., Osanai Y., Shouji A., Ujibe M., Ohtake T., Kimura K., Ishikawa M. Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice. Biol Pharm Bull: 2005; 28 527 530
170. Camargo C. A., Gomes-Marcondes M. C., Wutzki N. C., Aoyama H. Naringin inhibits tumor growth and reduces interleukin-6 and tumor necrosis factor α levels in rats with Walker 256 carcinosarcoma. Anticancer Res: 2012; 32 129 133
171. Oršolić N., Benković V., Lisičić D., Dikić D., Erhardt J., KneŽević A. H. Protective effects of propolis and related polyphenolic/flavonoid compounds against toxicity induced by irinotecan. Med Oncol: 2010; 27 1346 1358
172. KneŽević A. H., Dikić D., Lisičić D., Kopjar N., Oršolić N., Karabeg S., Benković V. Synergistic effects of irinotecan and flavonoids on Ehrlich ascites tumour-bearing mice. Basic Clin Pharmacol Toxicol: 2011; 109 343 349
173. Pang W. Y., Wang X. L., Mok S. K., Lai W. P., Chow H. K., Leung P. C., Yao X. S., Wong M. S. Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells. Br J Pharmacol: 2010; 159 1693 1703
174. Wong R. W., Rabie A. B. Effect of naringin on bone cells. J Orthop Res: 2006; 24 2045 2050
175. Wu J. B., Fong Y. C., Tsai H. Y., Chen Y. F., Tsuzuki M., Tang C. H. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. Eur J Pharmacol: 2008; 588 333 341
176. Li L., Zeng Z., Cai G. Comparison of neoeriocitrin and naringin on proliferation and osteogenic differentiation in MC3 T3-E1. Phytomedicine: 2011; 18 985 989
177. Ding P., Tang Q., Chen L. Effects of naringin on proliferation, differentiation and matrix mineralization of MC3 T3-E1 cells. Zhongguo Zhong Yao Za Zhi: 2009; 34 1712 1716
178. Zhang P., Dai K. R., Yan S. G., Yan W. Q., Zhang C., Chen D. Q., Xu B., Xu Z. W. Effects of naringin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cell. Eur J Pharmacol: 2009; 607 1 5
179. Wong R. W., Rabie A. B. Effect of naringin collagen graft on bone formation. Biomaterials: 2006; 27 1824 1831
180. Mandadi K., Ramirez M., Jayaprakasha G. K., Faraji B., Lihono M., Deyhim F., Patil B. S. Citrus bioactive compounds improve bone quality and plasma antioxidant activity in orchidectomized rats. Phytomedicine: 2009; 16 513 520
181. Zhou X., Zhang P., Zhang C., Zhu Z. Promotion of bone formation by naringin in a titanium particle-induced diabetic murine calvarial osteolysis model. J Orthop Res: 2010; 28 451 456
182. Habauzit V., Sacco S. M., Gil-Izquierdo A., Trzeciakiewicz A., Morand C., Barron D., Pinaud S., Offord E., Horcajada M. N. Differential effects of two citrus flavanones on bone quality in senescent male rats in relation to their bioavailability and metabolism. Bone: 2011; 49 1108 1116
183. Chen L. L., Lei L. H., Ding P. H., Tang Q., Wu Y. M. Osteogenic effect of Drynariae rhizoma extracts and Naringin on MC3 T3-E1 cells and an induced rat alveolar bone resorption model. Arch Oral Biol: 2011; 56 1655 1662
184. Yu X., Zhao X., Wu T., Zhou Z., Gao Y., Wang X., Zhang C. Q. Inhibiting wear particles-induced osteolysis with naringin. Int Orthop: 2013; 37 137 143
185. Ang E. S., Yang X., Chen H., Liu Q., Zheng M. H., Xu J. Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF- κ B and ERK activation. FEBS Lett: 2011; 585 2755 2762
186. Wei M., Yang Z., Li P., Zhang Y., Sse W. C. Anti-osteoporosis activity of naringin in the retinoic acid-induced osteoporosis model. Am J Chin Med: 2007; 35 663 667
187. Kawaguchi K., Maruyama H., Hasunuma R., Kumazawa Y. Suppression of inflammatory responses after onset of collagen-induced arthritis in mice by oral administration of the Citrus flavanone naringin. Immunopharmacol Immunotoxicol: 2011; 33 723 729
188. Nowak-Solinska E., Rabie A. B., Wong R. W., Lei S. W. The effect of naringin on early growth and development of the spheno-occipital synchondrosis as measured by the expression of PTHrP and Sox9 - an in vitro model. Eur J Orthod: 2013; 35 826 831
189. Li A., Zhao J. J., Liu J., Shi J. F., Rao G. Z., Wei H., Gou J. Z. Experimental study on the functional regulation of naringin in human periodontal ligament cells. Shanghai Kou Qiang Yi Xue: 2011; 20 561 566
190. Tsui V. W., Wong R. W., Rabie A. B. The inhibitory effects of naringin on the growth of periodontal pathogens in vitro. Phytother Res: 2008; 22 401 406
191. Wood N. The effects of dietary bioflavonoid (rutin, quercetin, and naringin) supplementation on physiological changes in molar crestal alveolar bone-cemento-enamel junction distance in young rats. J Med Food: 2004; 7 192 196
192. Wood N. The effects of selected dietary bioflavonoid supplementation on dental caries in young rats fed a high-sucrose diet. J Med Food: 2007; 10 694 701
193. Itoh K., Hirata N., Masuda M., Naruto S., Murata K., Wakabayashi K., Matsuda H. Inhibitory effects of Citrus hassaku extract and its flavanone glycosides on melanogenesis. Biol Pharm Bull: 2009; 32 410 415
194. Itoh K., Masuda M., Naruto S., Murata K., Matsuda H. Anti-allergic activity of unripe Citrus hassaku fruits extract and its flavanone glycosides on chemical substance-induced dermatitis in mice. J Nat Med: 2009; 63 443 450
195. Gao S., Li P., Yang H., Fang S., Su W. Antitussive effect of naringin on experimentally induced cough in Guinea pigs. Planta Med: 2011; 77 16 21
196. Kawaguchi K., Kikuchi S., Hasunuma R., Maruyama H., Ryll R., Kumazawa Y. Suppression of infection-induced endotoxin shock in mice by a citrus flavanone naringin. Planta Med: 2004; 70 17 22
197. Lakshmi V., Joseph S. K., Srivastava S., Verma S. K., Sahoo M. K., Dube V., Mishra S. K., Murthy P. K. Antifilarial activity in vitro and in vivo of some flavonoids tested against Brugia malayi. Acta Trop: 2010; 116 127 133
198. Zandi K., Teoh B. T., Sam S. S., Wong P. F., Mustafa M. R., Abubakar S. Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol J: 2011; 8 560
199. Duda-Chodak A. The inhibitory effect of polyphenols on human gut microbiota. J Physiol Pharmacol: 2012; 63 497 503
200. Céliz G., Daz M., Audisio M. C. Antibacterial activity of naringin derivatives against pathogenic strains. J Appl Microbiol: 2011; 111 731 738
201. Lambev I., Belcheva A., Zhelyazkov D. Flavonoids with antioxidant action (naringin and rutin) and the release of mastocytic and nonmastocytic histamine. Acta Physiol Pharmacol Bulg: 1980; 6 70 75
202. Oh H. A., Kim M. J., Shin T. Y., Kim H. M., Jeong H. J. The antiallergic mechanisms of Citrus sunki and bamboo salt (K-ALL) in an allergic rhinitis model. Exp Biol Med (Maywood): 2014; 239 83 93
203. Galati E. M., Monforte M. T., d'Aquino A., Miceli N., Di Mauro D., Sanogo R. Effects of naringin on experimental ulcer in rats. Phytomedicine: 1998; 5 361 366
204. Martín M. J., Marhuenda E., Pérez-Guerrero C., Franco J. M. Antiulcer effect of naringin on gastric lesions induced by ethanol in rats. Pharmacology: 1994; 49 144 150
205. Jang Y., Kim T. K., Shim W. S. Naringin exhibits in vivo prokinetic activity via activation of ghrelin receptor in gastrointestinal motility dysfunction rats. Pharmacology: 2013; 92 191 197
206. Oki K., Plonczynski M. W., Lam M. L., Gomez-Sanchez E. P., Gomez-Sanchez C. E. The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell line. Endocrinology: 2012; 153 4328 4335
207. Herrera M. D., Marhuenda E. Effect of naringin and naringenin on contractions induced by noradrenaline in rat vas deferens-I. Evidence for postsynaptic alpha-2 adrenergic receptor. Gen Pharmacol: 1993; 24 739 742
208. Shaik N., Zbidah M., Lang F. Inhibition of Ca(2+) entry and suicidal erythrocyte death by naringin. Cell Physiol Biochem: 2012; 30 678 686